LOKIMDO

Serial Number 99182521
681

Registration Progress

Application Filed
May 13, 2025
Under Examination
Approved for Publication
Published for Opposition
Jul 15, 2025
Registered

Basic Information

Serial Number
99182521
Filing Date
May 13, 2025
Published for Opposition
July 15, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
681
Status Date
Jun 23, 2025
Application
Pending
Classes
005

Rights Holder

Novartis AG

25
Address
CH-4002
Basel 4002
CH

Ownership History

Novartis AG

Original Applicant
25
Basel CH

Legal Representation

Attorney
Maury M. Tepper, III

Application History

5 events
Date Code Type Description
Jun 10, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2025 DOCK D ASSIGNED TO EXAMINER
May 13, 2025 MAFR O APPLICATION FILING RECEIPT MAILED
May 13, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 13, 2025 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification

International Classes
005